These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13355487)

  • 21. New synthetic thiocolchicine derivatives as lowtoxic anticancer agents.
    Lee SH; Park SK; Kim JM; Kim MH; Kim KH; Chun KW; Cho KH; Youn JY; Namgoong SK
    Arch Pharm (Weinheim); 2005 Dec; 338(12):582-9. PubMed ID: 16353277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors.
    Raspaglio G; Ferlini C; Mozzetti S; Prislei S; Gallo D; Das N; Scambia G
    Biochem Pharmacol; 2005 Jan; 69(1):113-21. PubMed ID: 15588720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LD50 and minimal effective antimitotic dose of colchicine in various rodents.
    FLEISCHMANN W; RUSSELL OQ; FLEISCHMANN SK
    Med Exp Int J Exp Med; 1962; 6():101-4. PubMed ID: 13893509
    [No Abstract]   [Full Text] [Related]  

  • 24. Derivatives of thiocolchicine and its applications to CEM cells treatment using 19F magnetic resonance ex vivo.
    Bartusik D; Tomanek B; Lattová E; Perreault H; Tuszynski J; Fallone G
    Bioorg Chem; 2010 Feb; 38(1):1-6. PubMed ID: 19944446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Deacetyl-N-methylcolchicine therapy of cutaneous epitheliomas].
    BASSET A; MONTFORT J
    Sem Med Prof Med Soc; 1958 Mar; 34(9):329-31. PubMed ID: 13543419
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of compound R-875 in very intense local algetic reactions in karyoklastic treatment by thiocolchicine: a case of intolerance with hallucinatory phenomena].
    HUANT E
    Therapie; 1958; 13(6):1036-41. PubMed ID: 13625216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of primary cancer of the liver by N-desacetyl-thiocolchicine].
    JORIS H; BASTIN JP
    Ann Soc Belg Med Trop (1920); 1961 Oct; 41():445-52. PubMed ID: 14452481
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antimitotic activity and toxicity of some osides of N-deacetylthiocolchicine].
    JEQUIER R; BRANCENI D; PETER-FALVI M
    Arch Int Pharmacodyn Ther; 1958 Apr; 114(3-4):435-8. PubMed ID: 13534834
    [No Abstract]   [Full Text] [Related]  

  • 29. Colchicinoids from Colchicum crocifolium Boiss.: a case study in dereplication strategies for (-)-colchicine and related analogues using LC-MS and LC-PDA techniques.
    Alali FQ; Gharaibeh A; Ghawanmeh A; Tawaha K; Oberlies NH
    Phytochem Anal; 2008; 19(5):385-94. PubMed ID: 18444231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects produced by N-desacetyl-thiocolchicine (R 261) on the hermaphrodite gland of adult Limnaea stagnalis].
    AUBRY R
    Therapie; 1957; 12(6):933-7. PubMed ID: 13496000
    [No Abstract]   [Full Text] [Related]  

  • 31. [N-desacetyl-thiocolchicine in antitumor chemotherapy].
    TRUHAUT R; SARACINO R
    Acta Unio Int Contra Cancrum; 1957; 13(3):431-41. PubMed ID: 13469601
    [No Abstract]   [Full Text] [Related]  

  • 32. Colchicine semisynthetics: chemotherapeutics for cancer?
    Sivakumar G
    Curr Med Chem; 2013; 20(7):892-8. PubMed ID: 23210778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Action of deacetyl-N-methylcolchicine on the segmentation and mitosis of the urodelan egg; comparison with colchicine and colchicoside.
    SENTEIN P
    Arch Anat Microsc Morphol Exp; 1956; 45(2):99-138. PubMed ID: 13373399
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents.
    Shi Q; Chen K; Morris-Natschke SL; Lee KH
    Curr Pharm Des; 1998 Jun; 4(3):219-48. PubMed ID: 10197041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of paclitaxel-thiocolchicine hybrids.
    Danieli B; Giardini A; Lesma G; Passarella D; Silvani A; Appendino G; Noncovich A; Fontana G; Bombardelli E; Sterner O
    Chem Biodivers; 2004 Feb; 1(2):327-45. PubMed ID: 17191851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest.
    Kim JH; Yoo HI; Kang HS; Ro J; Yoon S
    Biochem Biophys Res Commun; 2012 Feb; 418(1):98-103. PubMed ID: 22244892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of N-acylethanolamines and various antimitotic agents on apoptotic DNA fragmentation in conventionally normal and tumor tissue of human adrenals.
    Kostyuchenko N; Pushkarev V; Kashevarov G; Tronko M; Komisarenko I; Mikosha O
    Exp Oncol; 2005 Sep; 27(3):215-9. PubMed ID: 16244584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 7,11-epi-thyrsiferol: completion of its synthesis, evaluation of its antimitotic properties, and the further development of an SAR model.
    Nishiguchi GA; Graham J; Bouraoui A; Jacobs RS; Little RD
    J Org Chem; 2006 Aug; 71(16):5936-41. PubMed ID: 16872175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of colchicine. I. Effect of colchicine and its analogs on the reversed passive Arthus reaction and the carrageenan-induced hindpaw edema in the rat.
    Chang YH
    J Pharmacol Exp Ther; 1975 Jul; 194(1):154-8. PubMed ID: 125325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental cataract induced by antimitotic drugs].
    PIRODDA A
    Boll Soc Ital Biol Sper; 1957 May; 33(5):618-21. PubMed ID: 13479611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.